These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15863424)

  • 41. Ask the doctor. Is it okay to stop taking warfarin when atrial fibrillation stops?
    Lee R
    Harv Heart Lett; 2007 Jan; 17(5):7. PubMed ID: 17318981
    [No Abstract]   [Full Text] [Related]  

  • 42. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

  • 43. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 44. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 46. Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.
    Taggar JS; Lip GY
    Europace; 2008 Jan; 10(1):1-2. PubMed ID: 17906285
    [No Abstract]   [Full Text] [Related]  

  • 47. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: efficacy and safety in actual clinical practice.
    Ono A; Fujita T
    J Clin Neurosci; 2005 Nov; 12(8):891-4. PubMed ID: 16271478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next generation anticoagulants may push warfarin to the wayside.
    Kirsch B
    Manag Care; 2011 Feb; 20(2):33-6. PubMed ID: 21428128
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing stroke risk in patients with AF.
    Marshall G; Rankin AC
    Practitioner; 2007 Jun; 251(1695):30, 33-4, 36 passim. PubMed ID: 17654873
    [No Abstract]   [Full Text] [Related]  

  • 54. What's your stroke risk after atrial fibrillation? Novel risk-scoring method is precise but not perfect.
    Carlson MD
    Health News; 2003 Nov; 9(11):4-5. PubMed ID: 14619811
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prescription of warfarin after stroke care showed weaknesses. Procedures for documentation and indications should be improved, according to Malmö study].
    Zia E; Holmberg P; Pessah-Rasmussen H
    Lakartidningen; 2013 Jun 18-Jul 2; 110(25-26):1214-7. PubMed ID: 23865261
    [No Abstract]   [Full Text] [Related]  

  • 56. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines.
    Eiser AR
    Am J Med; 2014 Apr; 127(4):253-4. PubMed ID: 24333618
    [No Abstract]   [Full Text] [Related]  

  • 57. Is a novel anticoagulant right for your patient?
    Vandiver JW; Faulkner D; Erlandson M; Onysko M
    J Fam Pract; 2014 Jan; 63(1):22-8. PubMed ID: 24475463
    [No Abstract]   [Full Text] [Related]  

  • 58. [Bleeding problems of a patient with hypothyroidism].
    Paul R
    Duodecim; 2002; 118(13):1361-3. PubMed ID: 12239881
    [No Abstract]   [Full Text] [Related]  

  • 59. Anticoagulating elderly patients in atrial fibrillation.
    Maurice GL
    Chest; 1998 Sep; 114(3):949. PubMed ID: 9743200
    [No Abstract]   [Full Text] [Related]  

  • 60. Anticoagulation of older patients.
    Lip GY; Li-Saw-Hee FL
    Age Ageing; 2000 Jan; 29(1):3-4. PubMed ID: 10690686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.